The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...

Alshehri, E. (2026) The Diagnostic Conundrum of Recurrent High-Grade Vaginal Intraepithelial Neoplasia (VAIN) Following ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

Early detection and modern treatments make cervical cancer one of the most preventable and treatable cancers. Newport Women’s ...

TUESDAY, Dec. 2, 2025 (HealthDay News) -- In a practice guideline issued by the American Society for Radiation Oncology and published online Nov. 17 in Practical Radiation Oncology, recommendations ...

A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...

A new lab study exploited a unique aspect of metabolism in glioblastoma to boost the effectiveness of chemoradiation, turning the cancer's properties against itself. When you purchase through links on ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Chemotherapy significantly improves overall and cancer-specific survival in cervical cancer patients undergoing radiotherapy, especially in those aged 65 to 80 years. The benefits of chemotherapy ...

In the first randomized controlled trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not improve outcomes in patients with resected gallbladder cancer.

SAN FRANCISCO -- Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with ...

The sun has set on Johnson & Johnson’s SunRISe-2 study. J&J called a halt to the phase 3 bladder cancer trial after an interim look at the data showed the TAR-200 candidate was no better than ...